Drugabilis is a leading brand in the pharmaceutical industry, offering a wide range of drugability services to biotech, pharma, NPOs, TTO partners, CROs, and R&D organizations. With a vision since the early 90s, Drugabilis understands the challenges faced by major pharmaceutical companies in terms of drug development complexity, cost, global registration, and limited exploitation durations. Drugabilis' mission is to help clients achieve a higher return-on-investment by providing expertise and support in addressing pharmaceutical drugability-related issues.

They prioritize quality listening and proactivity to clarify project issues and offer clarified strategies in terms of scope and prioritization between studies to benefit their clients. Stay updated with Drugabilis through their news section, featuring the latest updates like the 2023 AFSSI Connexions event. They also provide useful resources and job offers for those interested in joining their team.

Contact Drugabilis for a true strategy about your pharmaceutical drugability needs